Loading...

Leef Brands Inc.

ICNAFPNK
HealthcareDrug Manufacturers - Specialty & Generic
$0.06
$0.00(0.00%)

Leef Brands Inc. ICNAF Peers

See (ICNAF) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ICNAF$0.06N/A0N/AN/AN/A
STMH$0.10+99900.00%125.8B-0.05-$1.89N/A
THCBF$0.02+2350.00%58.5B-2.45-$0.01N/A
MKKGY$26.67+1.87%58.4B18.14$1.47+2.14%
MKGAF$130.00-4.45%56.5B17.66$7.36+1.61%
HLNCF$5.42-1.28%48.8B25.79$0.21+2.01%
TKPHF$28.03+6.58%44.1B59.64$0.47+4.75%
KHRNF$0.01+79900.00%41.8B-0.80-$0.01N/A
IPSEY$30.45+3.22%40.3B25.17$1.21N/A
EVRRF$0.07+2780.00%25.6B-2.40-$0.03N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ICNAF vs STMH Comparison

ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICNAF stands at 0. In comparison, STMH has a market cap of 125.8B. Regarding current trading prices, ICNAF is priced at $0.06, while STMH trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICNAF currently has a P/E ratio of N/A, whereas STMH's P/E ratio is -0.05. In terms of profitability, ICNAF's ROE is N/A, compared to STMH's ROE of -2.75%. Regarding short-term risk, ICNAF is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.

Stock Price Comparison

Loading...

Frequently Asked Questions